Share this to:

Support & Insight for the Autumn of Life

Namenda for Alzheimer’s Back in Court


Will pharmacies run out of Namenda-IR® for Alzheimer’s? Namenda’s manufacturer is appealing for their right to pull it from pharmacy shelves. This would force patients who have not stocked up on Namenda-IR® to switch to Namenda-XR®. Will this be better for patients, or just more expensive?

With last September’s announcement of “Judge Ends Shortage of Namenda-IR for Alzheimer’s,” it seemed like the battle over Namenda was over. But this week, the company is appealing for their right to pull Namenda-IR off the market, despite an earlier court decision that this was not in the best interest of patients. (To understand what this 1.5 billion dollar fight is all about, go to Namenda Sued for “Forced Switch” of Alzheimer’s Drug.) It seems like the manufacturer, called Actavis, is not giving up so easily. CNBC reports:


  • CNBC
Notify of

Inline Feedbacks
View all comments
May 18, 2015 11:30 pm

Is there information about how this new med works for Alzheimer's patients compared to Aricept?
Reply to  Unknown
May 19, 2015 10:51 pm

Namenda and Aricept are 2 very different drugs for Alzheimer's that work in different ways, so it is hard to compare them. To really understand the basics of those differences, check out this video of an Advanced Seminar on Dementia Medications.

B. Berger

B. Berger

Visit Our Pages On:


This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor


Common Alzheimer's Medications Slow Cognitive Decline
Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to fiv...
Lilly's Donanemab: The 3rd New Alzheimer's Drug
Now, a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA),. The field of ne...
Leqembi Medication for Alzheimer's (Generic: Lecanemab)
Alzheimer's Drug Leqembi Gets Full FDA and MEDICARE Approval
First drug to modestly slow Alzheimer's cognitive decline, based on 1,800 patients.
Would love your thoughts, please comment.x
News, Treatments, Care Tips

Subscribe To The Weekly Newsletter

videos & articles on Research & Prevention
News to Get at the Truth

Subscribe To Our Weekly Newsletter